Medistim ASA Stock Forecast for 2023 - 2025 - 2030
Updated on 03/28/2024
Medistim ASA Stock Forecast and Price Target
Medistim ASA's most recent price target of kr210.00 for 2024 was provided by renowned analysts over the past few months, with an average prediction of kr210.00. If this prediction is correct, Medistim ASA's stock could rise by 14.75 percent from its current trading price. The potential increase for the stock is kr210.00 per share, with a possible range of kr210.00 to kr210.00. If you are not interested in MEDI stock, you may be interested in its competitors.
14.75% Upside
Medistim ASA Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Medistim ASA's Price has decreased from kr178.41 to kr0.00 – a 100.00% drop! In the next year, analysts believe that Fair Value will reach kr308.46 – an increase of 100.00%. For the next seven years, the forecast is for Fair Value to grow by 100.00%.
Medistim ASA Revenue Forecast for 2023 - 2025 - 2030
Medistim ASA's Revenue has seen impressive growth In the last three years, rising from kr356.21M to kr526.36M – a growth of 47.77%. In the next year, analysts believe that Revenue will reach kr543.91M – an increase of 3.33%. For the next seven years, the forecast is for Revenue to grow by 7.80%.
Medistim ASA Dividend per Share Forecast for 2023 - 2025 - 2030
In the last two years, Medistim ASA's Dividend per Share has grown by 50.00%, rising from kr3.00 to kr4.50. According to the 1 analysts polled, in the next year, Medistim ASA's Dividend per Share will fall by 18.44%, reaching kr3.67. By 2030, professionals believe that Medistim ASA's Dividend per Share will have decreased by 11.65%, falling to kr3.98.
Medistim ASA EBITDA Forecast for 2023 - 2025 - 2030
In the last three years, Medistim ASA's EBITDA has seen an increase, rising from kr111.95M to kr149.48M. This represents a growth of 33.52%. Analysts predict that Medistim ASA's EBITDA will increase in the upcoming year, reaching kr172.71M. This would represent an increase of 15.54%. Over the next seven years, experts predict that Medistim ASA's EBITDA will grow at a rate of 28.66%.
Medistim ASA EBIT Forecast for 2023 - 2025 - 2030
Medistim ASA's EBIT has seen growth In the last three years, going from kr95.49M to kr131.44M – a gain of 37.65% In the next year, analysts believe that EBIT will reach kr155.44M – an increase of 18.26%. For the next seven years, the forecast is forEBIT to grow by 33.82%.
Medistim ASA EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Medistim ASA's EPS has decreased from kr3.80 to kr0.00 – a 100.00% drop! In the next year, analysts believe that EPS will reach kr6.57 – an increase of 100.00%. For the next seven years, the forecast is for EPS to grow by 100.00%.